Proair Digihaler Inhalant
Product Images NDC 59310-117

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Proair Digihaler (NDC 59310-117). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Respiratory, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical structure diagram of the active ingredient in ProAir Digihaler 90 ug, showing a molecular structure with hydroxyl groups, an amino group, and sulfate components.*

FDA Label Image

Figure F (Image 10)

Illustration showing a person using the ProAir Digihaler 90 mcg inhaler by Teva Respiratory, LLC. The image demonstrates the correct technique, with a hand holding the inhaler near the person's mouth for inhalation.*

FDA Label Image

Figure G (Image 11)

An illustration of the ProAir Digihaler inhaler device showing a close-up of the mouthpiece area with a label pointing to the 'Vent' on the device. The inhaler is depicted in white and red colors.*

FDA Label Image

Figure H (Image 12)

An instructional illustration showing a hand holding a ProAir Digihaler inhaler while another hand removes or attaches a red protective cap at the mouthpiece. The image visually demonstrates proper handling or preparation of the ProAir Digihaler device for use.*

FDA Label Image

Steps 1-3 Image (Image 13)

Illustration titled 'Steps 1-3' showing a circular arrow suggesting a sequence or cycle of three steps, likely part of an instructional guide or usage directions for the ProAir Digihaler device.*

FDA Label Image

Teva Logo (Image 14)

FDA Label Image

Carton 59310-117-20 (Image 15)

ProAir Digihaler 90 mcg inhalation powder carton label containing 200 metered inhalations with 0.65 g net contents. The label shows the brand name, active ingredient albuterol sulfate, and includes safety information and storage instructions. Manufactured by Teva Respiratory, LLC, the design features a red and green dotted pattern with the Teva logo and barcode.*

FDA Label Image

Carton Image 59310-540-20 (Image 16)

Packaging label for ProAir Digihaler 90 mcg/actuation inhalation powder by Teva Respiratory, LLC. The label indicates albuterol sulfate as the active ingredient, with 200 metered inhalations containing 0.65 g net contents. It includes dosing and safety information, patient instructions, and contact details, marked prominently as a sample not for sale.*

FDA Label Image

Figure 1 (Image 2)

This image contains two line graphs comparing mean change from baseline FEV1 (L) over time points from pre-dose to 6 hours on Day 1 and Day 85. The graphs contrast ABS 180 mcg QID (red solid line) versus placebo (green dashed line), showing FEV1 values increasing and then gradually declining over time for the ABS treatment compared to relatively flat placebo values.*

FDA Label Image

Teva Logo (Image 3)

FDA Label Image

Teva Logo (Image 4)

FDA Label Image

Figure A (Image 5)

Illustration of the ProAir Digihaler inhaler device, showing key components including the red cap, mouthpiece, vent, electronic module, dose counter, and QR code.*

FDA Label Image

Figure B (Image 6)

Illustration showing the dose counter display on the ProAir Digihaler inhaler. It depicts the inhaler as full with 200 doses remaining and empty with 0 doses left, including visual representations of the dose counter numbers and background colors.*

FDA Label Image

Figure C (Image 7)

Illustration showing the use of the ProAir Digihaler inhaler. It demonstrates holding the inhaler device upright with one hand while removing the red cap with the other hand, following the indicated arrow direction.*

FDA Label Image

Figure D (Image 8)

Instructional illustration for ProAir Digihaler 90 ug/1 demonstrating correct and incorrect ways to remove the red cap from the inhaler device. The first image shows a correct method with a check mark, holding the inhaler upright and pulling the cap straight off. The next two images, marked with an X, show incorrect methods: twisting the cap horizontally and pulling the cap upward from the top.*

FDA Label Image

Figure E (Image 9)

An illustration showing the side profile of a person's face with dots emanating from the mouth, depicting the action of exhaling or aerosol spray being released.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.